Grifols SA

詳細情報 Grifols SA 企業名

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

企業情報

企業コードGRFS

会社名Grifols SA

上場日May 17, 2006

最高経営責任者「CEO」Mr. Jose Ignacio (Nacho) Abia

従業員数23833

証券種類Depository Receipt

決算期末May 17

本社所在地Parque Empresarial Can Sant Joan

都市SANT CUGAT DEL VALLES

証券取引所NASDAQ Global Select Consolidated

国Spain

郵便番号08174

電話番号34935710000

ウェブサイトhttps://www.grifols.com/

企業コードGRFS

上場日May 17, 2006

最高経営責任者「CEO」Mr. Jose Ignacio (Nacho) Abia

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Laura De La Cruz Galan

Non-Member Assistant Secretary of the Board

--

Ms. Nuria Martin Barnes

Non-Member Secretary of the Board of Directors

--

Mr. Joerg Schuettrumpf

Chief Scientific Innovation Officer

--

Mr. Paul S. Herendeen

Proprietary Director

--

Mr. Daniel Fleta Coit

Chief Industrial Services Officer

--

Mr. Victor Grifols Deu

Proprietary Director

--

Ms. Montserrat Munoz Abellana

Independent Director

--

Mr. Inigo Sanchez-Asiain Mardones

Independent Director

--

Ms. Susana Gonzalez Rodriguez

Independent Director

--

Mr. Jordi Balsells Valls

President - Plasma Procurement

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Laura De La Cruz Galan

Non-Member Assistant Secretary of the Board

--

Ms. Nuria Martin Barnes

Non-Member Secretary of the Board of Directors

--

Mr. Joerg Schuettrumpf

Chief Scientific Innovation Officer

--

Mr. Paul S. Herendeen

Proprietary Director

--

Mr. Daniel Fleta Coit

Chief Industrial Services Officer

--

Mr. Victor Grifols Deu

Proprietary Director

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q2

FY2021

FY2020

FY2019

データなし

地域別USD

会社名

収益

比率

United States/Canada

4.42B

56.67%

Rest of the World

1.71B

21.96%

European Union

1.21B

15.50%

Spain

457.59M

5.87%

事業別

地域別

データなし

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

Brandes Investment Partners, L.P.

9.97%

Capital World Investors

8.33%

Permian Investment Partners, LP

7.00%

Black Creek Investment Management, Inc.

4.91%

Armistice Capital LLC

3.59%

Other

66.19%

株主統計

比率

Brandes Investment Partners, L.P.

9.97%

Capital World Investors

8.33%

Permian Investment Partners, LP

7.00%

Black Creek Investment Management, Inc.

4.91%

Armistice Capital LLC

3.59%

Other

66.19%

種類

株主統計

比率

Investment Advisor

27.38%

Hedge Fund

18.23%

Investment Advisor/Hedge Fund

6.83%

Research Firm

4.06%

Pension Fund

1.13%

Sovereign Wealth Fund

0.75%

Bank and Trust

0.14%

Family Office

0.03%

Other

41.44%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

304

150.62M

58.33%

-8.38M

2025Q1

318

151.56M

58.69%

-8.09M

2024Q4

317

145.36M

56.29%

-25.01M

2024Q3

302

144.07M

55.96%

-19.66M

2024Q2

298

148.36M

57.63%

-6.71M

2024Q1

295

140.29M

54.61%

+6.03M

2023Q4

303

126.55M

49.26%

-7.36M

2023Q3

316

123.59M

48.19%

-7.60M

2023Q2

331

119.70M

46.67%

-25.54M

2023Q1

347

120.97M

47.21%

-11.90M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Brandes Investment Partners, L.P.

25.74M

9.97%

+5.25M

+25.59%

Mar 31, 2025

Capital World Investors

21.52M

8.33%

+388.01K

+1.84%

Mar 31, 2025

Permian Investment Partners, LP

18.08M

7%

+1.89M

+11.70%

Mar 31, 2025

Black Creek Investment Management, Inc.

12.69M

4.91%

+1.44M

+12.79%

Mar 31, 2025

Armistice Capital LLC

9.28M

3.59%

-758.00K

-7.55%

Mar 31, 2025

Millennium Management LLC

8.57M

3.32%

-783.49K

-8.38%

Mar 31, 2025

Soleus Capital Management, L.P.

7.09M

2.75%

+484.40K

+7.33%

Mar 31, 2025

Goldman Sachs & Company, Inc.

3.66M

1.42%

+275.63K

+8.15%

Mar 31, 2025

Harris Associates L.P.

3.44M

1.33%

-284.90K

-7.65%

Mar 31, 2025

Janus Henderson Investors

3.05M

1.18%

--

Mar 31, 2025

詳細を見る

関連ETF

更新時刻: Sat, Aug 2

銘柄名

比率

Brandes US Small-Mid Cap Value ETF

1.82%

Brandes International ETF

1.72%

Capital Group International Core Equity ETF

0.23%

iShares Biotechnology ETF

0.15%

ProShares Ultra Nasdaq Biotechnology

0.12%

Invesco Nasdaq Biotechnology ETF

0.12%

SPDR S&P Kensho New Economies Composite ETF

0.04%

ActivePassive International Equity ETF

0.03%

SPDR Portfolio Developed World ex-US ETF

0.01%

Fidelity Nasdaq Composite Index ETF

0.01%

詳細を見る

Brandes US Small-Mid Cap Value ETF

比率1.82%

Brandes International ETF

比率1.72%

Capital Group International Core Equity ETF

比率0.23%

iShares Biotechnology ETF

比率0.15%

ProShares Ultra Nasdaq Biotechnology

比率0.12%

Invesco Nasdaq Biotechnology ETF

比率0.12%

SPDR S&P Kensho New Economies Composite ETF

比率0.04%

ActivePassive International Equity ETF

比率0.03%

SPDR Portfolio Developed World ex-US ETF

比率0.01%

Fidelity Nasdaq Composite Index ETF

比率0.01%

配当金

過去5年間の配当金総支払額は 436.88M 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

May 25, 2021

GRFS.NB Interim Cash Dividend of gross USD 0.456586 paid on Jun 14, 2021 going ex on Jun 03, 2021

Jun 04, 2021

Jun 14, 2021

Jun 03, 2021

Oct 23, 2020

GRFS.NB Interim Cash Dividend of gross USD 0.201439 paid on Nov 09, 2020 going ex on Oct 30, 2020

Nov 02, 2020

Nov 09, 2020

Oct 30, 2020

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

10.845USD

Grifols SA

10.845

概要

企業名

金融